Inventor
CLARK EDWARD
US18 patents
⚠️ This page may combine multiple inventors who share the name “CLARK EDWARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERIAL SAS
11 patentsUS7192594B2Mar 20, 2007
Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
MERIAL SAS89 citations98
US7122192B2Oct 17, 2006
Porcine circoviruses, vaccines and diagnostic reagents
MERIAL SAS95 citations98
US6660272B2Dec 9, 2003
Porcine circoviruses, vaccines and diagnostic reagents
MERIAL SAS118 citations98
US6391314B1May 21, 2002
Porcine circoviruses vaccines diagnostic reagents
MERIAL SAS228 citations98
US6368601B1Apr 9, 2002
Porcine circovirus vaccine and diagnostics reagents
MERIAL SAS169 citations98
US7211379B2May 1, 2007
Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
MERIAL SAS80 citations96
US6517843B1Feb 11, 2003
Reduction of porcine circovirus-2 viral load with inactivated PCV-2
MERIAL SAS150 citations96
US7504206B2Mar 17, 2009
Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
MERIAL SAS4 citations73
US7833783B2Nov 16, 2010
Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
MERIAL SAS2 citations62
US7803926B2Sep 28, 2010
Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
MERIAL SAS2 citations62
US7803613B2Sep 28, 2010
Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
MERIAL SAS1 citations62
UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
3 patentsUS11549102B2Jan 10, 2023
Compositions and methods for antigen targeting to CD180
UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION3 citations82
US10563179B2Feb 18, 2020
Compositions and methods for antigen targeting to CD180
UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION6 citations82
US10196614B2Feb 5, 2019
Compositions and methods for antigen targeting to CD180
UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION8 citations82
UNIV WASHINGTON
3 patentsUS12018291B2Jun 25, 2024
Compositions and methods for antigen targeting to CD180
UNIV WASHINGTON2 citations71
US11324819B2May 10, 2022
Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV core antigen
UNIV WASHINGTON1 citations70
US12371672B2Jul 29, 2025
Compositions and methods for antigen targeting to CD180
UNIV WASHINGTON0 citations60